|
C-354005 |
1EA |
|
Cidofovir Impurity 3 |
| 100-69-6 |
B-361 |
1EA |
|
Betahistine EP Impurity A (2-Vinylpyridine) 2-乙烯基吡啶 |
| 1000673-59-5 |
R-1216 |
1EA |
|
Rizatriptan Impurity G 1，8-二硝基芘 |
| 10025-99-7 |
C-236006 |
1EA |
|
Potassium Tetrachloroplatinum(II) 氯亚铂酸钾 |
| 10025-99-7 |
C-236006 |
1EA |
|
Potassium Tetrachloroplatinum(II) 氯亚铂酸钾 |
| 10025-99-7 |
C-236006 |
1EA |
|
Potassium Tetrachloroplatinum(II) 氯亚铂酸钾 |
| 10028-24-7 |
P-834 |
1EA |
|
Disodium Hydrogen Phosphate Dihydrate 二水磷酸氢二钠 |
| 10028-24-7 |
P-834 |
1EA |
|
Disodium Hydrogen Phosphate Dihydrate 二水磷酸氢二钠 |
| 10028-24-7 |
P-834 |
1EA |
|
Disodium Hydrogen Phosphate Dihydrate 二水磷酸氢二钠 |
| 10028-24-7 |
P-834 |
1EA |
|
Disodium Hydrogen Phosphate Dihydrate 二水磷酸氢二钠 |
| 10034-93-2 |
H-055003 |
1EA |
|
Hydrazine Sulfate 硫酸肼, 99.%最低 |
| 100986-89-8 |
L-232 |
1EA |
|
Levofloxacin EP Impurity F (Levofloxacin Related Compound B) 左旋氧氟沙星羧酸, 97+% |
| 100986-89-8 |
L-232 |
1EA |
|
Levofloxacin EP Impurity F (Levofloxacin Related Compound B) 左旋氧氟沙星羧酸, 97+% |
| 100986-89-8 |
L-232 |
1EA |
|
Levofloxacin EP Impurity F (Levofloxacin Related Compound B) 左旋氧氟沙星羧酸, 97+% |
| 1010809-43-4 |
R-2710 |
1EA |
|
Ritonavir EP Impurity H 利托那韦杂质H |
| 1010809-43-4 |
R-2710 |
1EA |
|
Ritonavir EP Impurity H 利托那韦杂质H |
| 102625-64-9 |
P-0111 |
1EA |
|
Pantoprazole EP Impurity B (Pantoprazole Sulfide) 5-(二氟甲氧基)-2-{[(3,4-二甲氧基-2-吡啶基)甲基]硫}-1H-苯并咪唑 |
| 102625-64-9 |
P-0111 |
1EA |
|
Pantoprazole EP Impurity B (Pantoprazole Sulfide) 5-(二氟甲氧基)-2-{[(3,4-二甲氧基-2-吡啶基)甲基]硫}-1H-苯并咪唑 |
| 102625-64-9 |
P-0111 |
1EA |
|
Pantoprazole EP Impurity B (Pantoprazole Sulfide) 5-(二氟甲氧基)-2-{[(3,4-二甲氧基-2-吡啶基)甲基]硫}-1H-苯并咪唑 |
| 103-76-4 |
A-1450 |
1EA |
|
1-Piperazineethanol N-(2-羟乙基)哌嗪 |
| 103628-48-4 |
S-111 |
1EA |
|
Sumatriptan Succinate 琥珀酸舒马坦 |
| 103659-08-1 |
N-103006 |
1EA |
|
N-Nitroso-2-Methylthiazolidine-4-Carboxylic Acid N-亚硝基-2-甲基噻唑烷4-羧酸 |
| 103733-49-9 |
Q-027 |
1EA |
|
Quinapril Impurity D 喹那普利杂质D |
| 103733-49-9 |
Q-027 |
1EA |
|
Quinapril Impurity D 喹那普利杂质D |
| 103733-65-9 |
I-119005 |
1EA |
|
Icatibant Impurity 4 (R)-(+)-1,2,3,4-四氢异喹啉-3-羧酸 |
| 103733-65-9 |
I-119005 |
1EA |
|
Icatibant Impurity 4 (R)-(+)-1,2,3,4-四氢异喹啉-3-羧酸 |
| 103784-04-9 |
D-4922 |
1EA |
|
Domperidone Impurity 14 |
| 10389-51-2 |
M-208003 |
1EA |
|
4-(4-Nitrophenyl)morpholine 4-(4-硝基苯基)吗啉, 98% |
| 104713-75-9 |
B-414 |
1EA |
|
Barnidipine (S)-3-((S)-1-苄基吡咯烷-3-基)-5-甲基-2,6-二甲基-4-(3-硝基苯基)-1,4-二氢吡啶-3,5-二羧酸酯 |
| 104872-06-2 |
O-01817 |
1EA |
|
Orlistat USP Related Compound A (3S,4S)-3-己基-4-[(2R)-2-羟基十三烷基]-2-氧杂环丁酮 |
| 104872-06-2 |
O-01817 |
1EA |
|
Orlistat USP Related Compound A (3S,4S)-3-己基-4-[(2R)-2-羟基十三烷基]-2-氧杂环丁酮 |
| 105356-89-6 |
T-757 |
1EA |
|
Terazosin EP Impurity G 1-(4-氨基-6-羟基-7-甲氧基-2-喹唑啉基)-4-[(四氢-2-呋喃基)羰基]哌嗪 |
| 105356-89-6 |
T-757 |
1EA |
|
Terazosin EP Impurity G 1-(4-氨基-6-羟基-7-甲氧基-2-喹唑啉基)-4-[(四氢-2-呋喃基)羰基]哌嗪 |
| 105627-80-3 |
F-6136 |
1EA |
|
Fasudil Impurity 32 |
| 106135-28-8 |
O-02130 |
1EA |
|
Omeprazole Impurity 48 5-甲氧基-1H-苯并咪唑-2-磺酸 |
| 106461-41-0 |
I-0336 |
1EA |
|
Itraconazole Impurity 10 2-(仲丁基)-4-(4-(4-(4-羟基苯基)哌嗪-1-基)苯基)-2,4-二氢-3H-1,2,4-三唑-3-酮 |
| 106461-41-0 |
I-0336 |
1EA |
|
Itraconazole Impurity 10 2-(仲丁基)-4-(4-(4-(4-羟基苯基)哌嗪-1-基)苯基)-2,4-二氢-3H-1,2,4-三唑-3-酮 |
| 106939-30-4 |
L-2331 |
1EA |
|
N-Ethyl Levofloxacin (3S)-10-(4-乙基-1-哌嗪基)-9-氟-2,3-二氢-3-甲基-7-氧代-7H-吡啶并[1,2,3-DE]-1,4-苯并恶嗪-6-羧酸 |
| 106939-30-4 |
L-2331 |
1EA |
|
N-Ethyl Levofloxacin (3S)-10-(4-乙基-1-哌嗪基)-9-氟-2,3-二氢-3-甲基-7-氧代-7H-吡啶并[1,2,3-DE]-1,4-苯并恶嗪-6-羧酸 |
| 106939-34-8 |
L-2326 |
1EA |
|
Levofloxacin Impurity 10 (S)-乙基 9,1-二氟-3-甲基-7-羰基-3,7-二氢-2H-[1,4]恶嗪并[2,3,4-ij]喹啉-6-羧酸酯 |
| 106941-25-7 |
A-361 |
1EA |
|
Adefovir 阿德福韦 |
| 1072902-75-0 |
O-01820 |
1EA |
|
Orlistat USP Related Compound E N-甲酰基-L-异亮氨酸 (1S)-1-[[(2S,3S)-3-己基-4-氧代-2-氧杂环丁基]甲基]十二烷基酯 |
| 1072902-75-0 |
O-01820 |
1EA |
|
Orlistat USP Related Compound E N-甲酰基-L-异亮氨酸 (1S)-1-[[(2S,3S)-3-己基-4-氧代-2-氧杂环丁基]甲基]十二烷基酯 |
| 1076-38-6 |
W-0129 |
1EA |
|
Warfarin EP Impurity B (4-Hydroxy Coumarin) 4-羟基香豆素 |
| 108612-45-9 |
M-191001 |
1EA |
|
Mizolastine 2-((1-(1-(4-氟苄基)-1H-苯并[d]咪唑-2-基)-哌啶-4-基)(甲基)胺)嘧啶-4(1H)-酮 |
| 109-01-3 |
P-228014 |
1EA |
|
1-Methylpiperazine 1-甲基哌嗪 |
| 109010-60-8 |
B-019 |
1EA |
|
Benazepril Related Compound F (S)-2-(2-氧代-3-氨基-2,3,4,5-四氢苯并[b]氮杂卓-1-基)乙酸叔丁酯 |
| 1092939-17-7 |
R-093001 |
1EA |
|
Ruxolitinib Phosphate (R)-3-(4-(7H-吡咯并[2,3-d]嘧啶-4-基)-1H-吡唑-1-基)-3-环戊基丙腈 磷酸酯 |
| 1092939-17-7 |
R-093001 |
1EA |
|
Ruxolitinib Phosphate (R)-3-(4-(7H-吡咯并[2,3-d]嘧啶-4-基)-1H-吡唑-1-基)-3-环戊基丙腈 磷酸酯 |
| 110-82-7 |
C-351007 |
1EA |
|
Cyclohexane 环己烷 |
| 110548-07-7 |
L-2324 |
1EA |
|
Levofloxacin Impurity 8 (R)-氧氟沙星羧酸 |
| 1106685-61-3 |
A-3118 |
1EA |
|
Ambrisentan Impurity 5 |
| 1122-58-3 |
V-0119 |
1EA |
|
Valaciclovir EP Impurity G (Valacyclovir USP Related Compound G, DMAP) 4-二甲氨基吡啶 |
| 112233-24-6 |
R-0322 |
1EA |
|
Ranitidine Impurity 8 雷尼替丁杂质8 |
| 112233-24-6 |
R-0322 |
1EA |
|
Ranitidine Impurity 8 雷尼替丁杂质8 |
| 112885-41-3 |
M-541 |
1EA |
|
Mosapride 4-氨基-5-氯-2-乙氧基-N-((4-(4-氟苄基)-2-吗啉基)甲基)苯甲酰胺 |
| 1141-23-7 |
B-404 |
1EA |
|
Baclofen EP Impurity B 3-(4-氯苯基)戊二酰胺酸, 97% |
| 114457-94-2 |
B-462 |
1EA |
|
Bortezomib Impurity 36 N-(吡嗪基羰基)-L-苯基丙氨酸 |
| 1148113-53-4 |
A-324 |
1EA |
|
(1R,2R,3R)-Aprepitant |
| 1148113-53-4 |
A-324 |
1EA |
|
(1R,2R,3R)-Aprepitant |
| 1159977-56-6 |
Z-077 |
1EA |
|
Ziprasidone EP Impurity B 齐拉西酮杂质B |
| 1159977-56-6 |
Z-077 |
1EA |
|
Ziprasidone EP Impurity B 齐拉西酮杂质B |
| 1166228-30-3 |
B-0217 |
1EA |
|
Bicalutamide Related Compound B |
| 1173706-34-7 |
S-0636 |
1EA |
|
Cyclopentynafil |
| 117548-22-8 |
F-139001 |
1EA |
|
5(6)-Carboxyfluorescein N-Hydrosuccinimide ester 5(6)-羧基荧光素琥珀酰亚胺酯 |
| 118-00-3 |
G-245 |
1EA |
|
Guanosine 鸟嘌呤核苷(99%) |
| 118072-93-8 |
Z-171 |
1EA |
|
Zoledronic Acid (1-羟基-2-(1H-咪唑-1-基)乙烷-1,1-二基)二磷酸 |
| 118072-93-8 |
Z-171 |
1EA |
|
Zoledronic Acid (1-羟基-2-(1H-咪唑-1-基)乙烷-1,1-二基)二磷酸 |
| 118288-08-7 |
L-471 |
1EA |
|
Lafutidine (Z)-2-((呋喃-2-基甲基)亚磺酰基)-N-(4-((3-(哌啶-1-基甲基)吡啶-2-基)氧基)丁-2-烯-1-基)乙酰胺 |
| 118288-08-7 |
L-476 |
1EA |
|
Lafutidine-d10 拉呋替丁-D10 |
| 1185883-40-2 |
E-0626 |
1EA |
|
Ezetimibe Impurity 14 |
| 1185883-40-2 |
E-0626 |
1EA |
|
Ezetimibe Impurity 14 |
| 119-84-6 |
C-1619 |
1EA |
|
3,4-Dihydro Coumarin 3,4-二氢香豆素 |
| 119302-24-8 |
R-321 |
1EA |
|
Rocuronium Bromide EP Impurity A (2b,3a,5a,16b,17b)-17-乙酰氧基-3-羟基-2-(4-吗啉基)-16-(1-吡咯烷基)雄烷 |
| 119699-81-9 |
E-2041 |
1EA |
|
Erythromycin Impurity 7 6-O-甲基-2\',4\'\'-双-O-(三甲基硅烷基)红霉素9-[O-(1-乙氧基-1-甲基乙基)肟] |
| 1200-22-2 |
T-8814 |
1EA |
|
(R)-alpha-Thioctic Acid (R)-α-硫辛酸 |
| 1201920-88-8 |
T-467 |
1EA |
|
Triclabendazole Impurity 1 乙腈中三氯苯达唑酮溶液，1μg/mL |
| 1204818-19-8 |
S-2012 |
1EA |
|
Sitagliptin Impurity 17 (R)-3-氨基-4-(2,4,5-三氟苯基)丁酸盐酸盐 |
| 121-66-4 |
T-449 |
1EA |
|
Nitazoxanide USP Related Compound A 2-氨基-5-硝基噻唑 |
| 122111-01-7 |
G-2627 |
1EA |
|
Gemcitabine Impurity 15 2-脱氧-2,2-二氟戊呋喃糖-1-酮-3,5-二安息香酸盐 |
| 1222-05-5 |
G-159001 |
1EA |
|
Galaxolide 1,3,4,6,7,8-六氢-4,6,6,7,8,8-六甲基环戊[g]-2-苯并吡喃 (约5%于邻苯二甲酸二乙酯中) |
| 1222-05-5 |
G-159002 |
1EA |
|
Galaxolide-13C-d2 |
| 122320-73-4 |
R-089 |
1EA |
|
Rosiglitazone 罗格列酮 |
| 122883-93-6 |
Z-072 |
1EA |
|
Ziprasidone HCl 5-(2-(4-(苯并[d]异噻唑-3-基)哌嗪-1-基)-乙基)-6-氯吲哚林-2-酮 盐酸盐 |
| 122883-93-6 |
Z-072 |
1EA |
|
Ziprasidone HCl 5-(2-(4-(苯并[d]异噻唑-3-基)哌嗪-1-基)-乙基)-6-氯吲哚林-2-酮 盐酸盐 |
| 1231930-82-7 |
A-253001 |
1EA |
|
Abemaciclib Mesylate Abemaciclib (LY2835219) |
| 1231930-82-7 |
A-253001 |
1EA |
|
Abemaciclib Mesylate Abemaciclib (LY2835219) |
| 125988-01-4 |
A-12100 |
1EA |
|
Atorvastatin Impurity 59 叔-丁基 (R)-6-氰基-5-羟基-3-羰基己酸酯 |
| 1261268-85-2 |
M-2612 |
1EA |
|
Manidipine Impurity 1 Oxalate 乙酰乙酸[2-(4-二苯甲基-1-哌嗪基)]乙酯草酸盐 |
| 1263278-77-8 |
T-335 |
1EA |
|
Trazodone BP Impurity C HCl 曲唑酮相关物质C |
| 1263278-80-3 |
T-336 |
1EA |
|
Trazodone Hydrochloride BP Impurity D HCl 曲唑酮杂质D |
| 127852-28-2 |
F-3633 |
1EA |
|
Fosaprepitant Impurity 25 (1R)-1-(3,5-双三氟甲基苯基)乙醇 |
| 129083-44-9 |
F-1910 |
1EA |
|
Famotidine EP Impurity E |
| 129722-25-4 |
A-146 |
1EA |
|
Aripiprazole EP Impurity E (Dehydro Aripiprazole) 7-(4-(4-(2,3-二氯苯基)哌嗪-1-基)丁氧基)喹啉-2(1H)-酮 |
| 13035-61-5 |
R-0416 |
1EA |
|
Ribavirin Impurity 2 四-O-乙酰基-β-D-呋喃核糖 |
| 131-48-6 |
S-119002 |
1EA |
|
N-Acetylneuraminic Acid N-(-)-乙酰甘露糖胺丙酮酸 |
| 1312679-00-7 |
M-713 |
1EA |
|
Methazolamide Sulfonic Acid |
| 13127-18-9 |
E-2021 |
1EA |
|
Erythromycin A 9-Oxime (Mixture of Z and E Isomers) 红霉素A肟 |
| 131707-23-8 |
A-116001 |
1EA |
|
Arbidol HCl 乙基 6-溴-4-((二甲氨基)甲基)-5-羟基-1-甲基-2-((苯基硫代)甲基)-1H-吲哚-3-羧酸酯 盐酸盐 |
| 131926-99-3 |
L-032 |
1EA |
|
Lansoprazole EP Impurity B (Lansoprazole Sulfone) 右旋兰索拉唑杂质B |
| 131986-45-3 |
X-009001 |
1EA |
|
Xanomeline 3-(己基氧基)-4-(1-甲基-1,2,5,6-四氢吡啶-3-基)-1,2,5-噻二唑 |
| 133099-04-4 |
D-171 |
1EA |
|
Darifenacin 2-(1-(2-(2,3-二氢苯并呋喃-5-基)乙基)-吡咯烷-3-基)-2,2-二苯基乙酰胺 |
| 133099-04-4 |
D-172 |
1EA |
|
Darifenacin-d4 |
| 1332724-03-4 |
C-0938 |
1EA |
|
Citalopram EP Impurity B Oxalate (3-Hydroxy Citalopram Oxalate) |
| 1333233-46-7 |
S-0635 |
1EA |
|
Dithio-Desmethyl Carbodenafil 二硫代-脱甲基 - 昔多芬 |
| 13463-41-7 |
Z-026001 |
1EA |
|
Zinc Pyrithione 2-巯基吡啶 N-氧化锌盐 |
| 135459-87-9 |
R-164 |
1EA |
|
Strontium Ranelate 锶 2,2'-((5-羧基-4-(羧酸甲基)-3-氰基噻吩-2-基)氮烷二基)二乙酸酯 |
| 135459-87-9 |
R-164 |
1EA |
|
Strontium Ranelate 锶 2,2'-((5-羧基-4-(羧酸甲基)-3-氰基噻吩-2-基)氮烷二基)二乙酸酯 |
| 135459-87-9 |
R-164 |
1EA |
|
Strontium Ranelate 锶 2,2'-((5-羧基-4-(羧酸甲基)-3-氰基噻吩-2-基)氮烷二基)二乙酸酯 |
| 136-95-8 |
P-1214 |
1EA |
|
Pramipexole Impurity 28 (Benzo[d]thiazol-2-Amine) 2-氨基苯并噻唑 |
| 1363173-34-5 |
G-077 |
1EA |
|
Granisetron EP Impurity I |
| 136434-34-9 |
D-114 |
1EA |
|
Duloxetine HCl 盐酸度洛西汀 |
| 136434-34-9 |
D-114 |
1EA |
|
Duloxetine HCl 盐酸度洛西汀 |
| 137-00-8 |
T-8423 |
1EA |
|
Thiamine Impurity 2 4-甲基5-噻唑乙醇 |
| 137281-23-3 |
P-681 |
1EA |
|
Pemetrexed (S)-2-(4-(2-(2-氨基-4-羰基-4,7-二氢-1H-吡咯-[2,3-d]嘧啶-5-基)乙基)苯甲酰胺基)戊烷二酸 |
| 138261-41-3 |
I-117001 |
1EA |
|
Imidacloprid 吡虫啉 |
| 138402-11-6 |
I-021 |
1EA |
|
Irbesartan 3-((2'-(1H-四唑-5-基)-[1,1'-二苯基]-4-基)-甲基)-2-丁基-1,3-二氮杂螺[4.4]壬-1-烯-4-酮 |
| 138564-59-7 |
O-0114 |
1EA |
|
Olanzapine EP Impurity A 5-甲基-2-(2-硝基苯胺基)-3-氰基噻吩 |
| 138900-27-3 |
S-150004 |
1EA |
|
Sertindole Impurity 2 5-氯-1-(4-氟苯基)-3-(哌啶-4-基)-1H-吲哚 |
| 1391068-25-9 |
L-0714 |
1EA |
|
Linezolid Impurity 32 HCl 盐酸利奈唑胺杂质D |
| 139264-69-0 |
Z-0217 |
1EA |
|
Zolmitriptan USP Related Compound B 佐米曲坦USP RC B |
| 139264-69-0 |
Z-0217 |
1EA |
|
Zolmitriptan USP Related Compound B 佐米曲坦USP RC B |
| 139481-72-4 |
C-0113 |
1EA |
|
N-Trityl Candesartan 2-乙氧基-1-((2'-(1-三苯甲基-1H-四唑-5-基)-[1,1'-二苯基]-4-基)甲基)-1H-苯并[d]咪唑-7-羧酸 |
| 139481-72-4 |
C-0113 |
1EA |
|
N-Trityl Candesartan 2-乙氧基-1-((2'-(1-三苯甲基-1H-四唑-5-基)-[1,1'-二苯基]-4-基)甲基)-1H-苯并[d]咪唑-7-羧酸 |
| 141-79-7 |
C-136005 |
1EA |
|
Cilastatin EP Impurity D 4-甲基-3戊烯-2-酮 |
| 141109-19-5 |
C-1326 |
1EA |
|
Clopidogrel EP Impurity F HCl (S)-甲基 2-(2-氯苯基)-2-((2-(噻吩-2-基)乙基)胺)乙酸酯 盐酸盐 |
| 141109-19-5 |
C-1326 |
1EA |
|
Clopidogrel EP Impurity F HCl (S)-甲基 2-(2-氯苯基)-2-((2-(噻吩-2-基)乙基)胺)乙酸酯 盐酸盐 |
| 141625-93-6 |
D-511 |
1EA |
|
Dronedarone HCl 盐酸决奈达隆 |
| 141942-85-0 |
A-1296 |
1EA |
|
Atorvastatin Impurity 55 (R)-(-)-4-氰基-3-羟基丁酸乙酯(含有数量不等的酸酐) |
| 141942-85-0 |
A-1296 |
1EA |
|
Atorvastatin Impurity 55 (R)-(-)-4-氰基-3-羟基丁酸乙酯(含有数量不等的酸酐) |
| 142341-05-7 |
A-364 |
1EA |
|
Adefovir Dipivoxyl Impurity A ((((2-(6-氨基-9H-嘌呤-9-基)乙氧基)甲基)-(羟基)磷酰基)氧基)甲基 三甲基乙酸酯 |
| 14281-83-5 |
M-210005 |
1EA |
|
Zinc Bisglycinate 甘氨酸锌盐一水合物[用于蛋白质研究] |
| 14281-83-5 |
M-210005 |
1EA |
|
Zinc Bisglycinate 甘氨酸锌盐一水合物[用于蛋白质研究] |
| 143527-70-2 |
D-1922 |
1EA |
|
Docetaxel Related Compound 3 (4S,5R)-3-(叔-丁氧羰基)-2,2-二甲基-4-苯基恶唑啉-5-羧酸 |
| 143900-44-1 |
I-061010 |
1EA |
|
Ibrutinib Impurity 7 (S)-1-Boc-3-羟基哌啶, 97% |
| 143900-44-1 |
I-061010 |
1EA |
|
Ibrutinib Impurity 7 (S)-1-Boc-3-羟基哌啶, 97% |
| 144689-63-4 |
O-083 |
1EA |
|
Olmesartan Medoxomil (5-甲基-2-羰基-1,3-二氧l-4-基)甲基 1-((2'-(1H-四唑-5-基)-[1,1'-二苯基]4-基)甲基)-4-(2-羟基丙烷-2-基)-2-丙基-1H-咪唑-5-羧酸酯 |
| 144689-63-4 |
O-083 |
1EA |
|
Olmesartan Medoxomil (5-甲基-2-羰基-1,3-二氧l-4-基)甲基 1-((2'-(1H-四唑-5-基)-[1,1'-二苯基]4-基)甲基)-4-(2-羟基丙烷-2-基)-2-丙基-1H-咪唑-5-羧酸酯 |
| 146447-26-9 |
L-4713 |
1EA |
|
Lafutidine Impurity 8 Maleate (Z)-2-(4-((4-(哌啶-1-基甲基)吡啶-2-基)-氧基)丁-2-烯-1-基)异吲哚林-1,3-二酮 马来酸酯 |
| 146447-26-9 |
L-4713 |
1EA |
|
Lafutidine Impurity 8 Maleate (Z)-2-(4-((4-(哌啶-1-基甲基)吡啶-2-基)-氧基)丁-2-烯-1-基)异吲哚林-1,3-二酮 马来酸酯 |
| 14649-03-7 |
I-131003 |
1EA |
|
(S)-(-)-1-Phenylethyl isocyanate (S)-(-)-1-苯乙基异氰酸酯 |
| 147-85-3 |
E-0227 |
1EA |
|
Enalapril Impurity 5 L-脯氨酸 |
| 147403-65-4 |
A-8425 |
1EA |
|
Azilsartan Impurity 2 甲基 2-乙氧基-1-((2'-(N-羟基甲脒基)-[1,1'-二苯基]-4-基)甲基)-1H-苯并[d]咪唑-7-羧酸酯 |
| 1483-01-8 |
A-9235 |
1EA |
|
L-Homoarginine Hydrochloride L-高精氨酸 盐酸盐 |
| 1483-01-8 |
A-9235 |
1EA |
|
L-Homoarginine Hydrochloride L-高精氨酸 盐酸盐 |
| 149524-42-5 |
T-163036 |
1EA |
|
Tedizolid Impurity 33 (R)-3-(3-氟苯基)-5-(羟甲基)-恶唑啉-2-酮 |
| 149524-42-5 |
T-163036 |
1EA |
|
Tedizolid Impurity 33 (R)-3-(3-氟苯基)-5-(羟甲基)-恶唑啉-2-酮 |
| 149809-43-8 |
P-3888 |
1EA |
|
Posaconazole Diastereoisomer Related Compound 8 对甲基苯磺酸(3S,5R)-5-(2,4-二氟苯基)-5-[(1H-1,2,4-三唑-1-基)甲基]恶烷-3-基甲酯 |
| 151907-79-8 |
P-124038 |
1EA |
|
Peramivir Impurity 34 (1S,4R)-Boc-4-氨环戊-2-烯-羧酸 |
| 15199-43-6 |
S-3530 |
1EA |
|
Salicylic Acid Impurity 12-d6 (Dimethyl Sulfate-d6) 氘代硫酸二甲酯 |
| 15199-43-6 |
S-3530 |
1EA |
|
Salicylic Acid Impurity 12-d6 (Dimethyl Sulfate-d6) 氘代硫酸二甲酯 |
| 152305-23-2 |
Z-0221 |
1EA |
|
Zolmitriptan EP Impurity E (Zolmitriptan USP Related Compound G) (S)-4-(4-氨基苄基)-2-噁唑烷酮 |
| 152305-23-2 |
Z-0221 |
1EA |
|
Zolmitriptan EP Impurity E (Zolmitriptan USP Related Compound G) (S)-4-(4-氨基苄基)-2-噁唑烷酮 |
| 152305-23-2 |
Z-0221 |
1EA |
|
Zolmitriptan EP Impurity E (Zolmitriptan USP Related Compound G) (S)-4-(4-氨基苄基)-2-噁唑烷酮 |
| 152305-23-2 |
Z-0221 |
1EA |
|
Zolmitriptan EP Impurity E (Zolmitriptan USP Related Compound G) (S)-4-(4-氨基苄基)-2-噁唑烷酮 |
| 15362-40-0 |
D-0610 |
1EA |
|
Diclofenac Lactam (Diclofenac Impurity A) 1-(2,6-二氯苯基)吲哚林-2-酮 |
| 15362-40-0 |
V-241 |
1EA |
|
Voltindole (Aceclofenac EP Impurity I, Diclofenac EP Impurity A, Diclofenac Amide) 1-(2,6-二氯苯基)吲哚林-2-酮 |
| 154057-58-6 |
P-6469 |
1EA |
|
Pitavastatin Impurity 44 Bromide [[2-环丙基-4-(4-氟苯基)-3-喹啉基]甲基]三苯基溴化膦 |
| 154127-19-2 |
B-2022 |
1EA |
|
Brinzolamide Impurity 12 |
| 154127-19-2 |
B-2022 |
1EA |
|
Brinzolamide Impurity 12 |
| 154127-42-1 |
B-205 |
1EA |
|
Brinzolamide Related Compound A (S)-4-羟基-2-(3-甲氧基丙基)-3,4-二氢-2H-噻吩并-[3,2-e][1,2]噻嗪-6-磺酰胺 1,1-二氧 |
| 154127-42-1 |
B-205 |
1EA |
|
Brinzolamide Related Compound A (S)-4-羟基-2-(3-甲氧基丙基)-3,4-二氢-2H-噻吩并-[3,2-e][1,2]噻嗪-6-磺酰胺 1,1-二氧 |
| 154361-50-9 |
C-352 |
1EA |
|
Capecitabine 卡培他滨 |
| 1561176-27-9 |
L-0781 |
1EA |
|
Linezolid Impurity 63 利奈唑胺杂质63 |
| 1561176-27-9 |
L-0781 |
1EA |
|
Linezolid Impurity 63 利奈唑胺杂质63 |
| 15663-27-1 |
C-236001 |
1EA |
|
Cisplatin 顺二氯二氨基铂 |
| 15663-27-1 |
C-236001 |
1EA |
|
Cisplatin 顺二氯二氨基铂 |
| 160844-75-7 |
F-3912 |
1EA |
|
Febuxostat Impurity 3 2-(3-氰基-4-异丁氧基苯基)-4-甲基噻唑-5-甲酸乙酯 |
| 160844-75-7 |
F-3912 |
10mg |
|
Febuxostat Impurity 3 2-(3-氰基-4-异丁氧基苯基)-4-甲基噻唑-5-甲酸乙酯 |
| 1610690-08-8 |
L-0748 |
1EA |
|
Linezolid Impurity 29 (S)-1-氯-3-((3-氟-4-吗啉苯基)氨基)丙烷-2-醇 |
| 1610690-08-8 |
L-0748 |
1EA |
|
Linezolid Impurity 29 (S)-1-氯-3-((3-氟-4-吗啉苯基)氨基)丙烷-2-醇 |
| 161715-27-1 |
T-9913 |
1EA |
|
Tebipenem Pivoxil Impurity 5 3-羟基-1-(1,3-噻唑啉-2-基)氮杂环丁烷 |
| 161796-78-7 |
O-029 |
1EA |
|
Esomeprazole Sodium Salt 钠 (S)-6-甲氧基-2-(((4-甲氧基-3,5-二甲基吡啶-2-基)甲基)亚磺酰基)苯并[d]咪唑-1-化合物 |
| 161796-78-7 |
O-029 |
1EA |
|
Esomeprazole Sodium Salt 钠 (S)-6-甲氧基-2-(((4-甲氧基-3,5-二甲基吡啶-2-基)甲基)亚磺酰基)苯并[d]咪唑-1-化合物 |
| 161797-99-5 |
F-3953 |
1EA |
|
Febuxostat Impurity 39 2-(4-羟基苯基)-4-甲基噻唑-5-羧酸乙酯, 97% |
| 161798-02-3 |
F-3914 |
1EA |
|
Febuxostat Impurity 5 2-(3-氰基-4-羟基苯基)-4-甲基-1,3-噻唑-5-羧酸乙酯 |
| 1619-34-7 |
P-116017 |
1EA |
|
Penehyclidine Impurity 15 3-喹核醇 |
| 162537-11-3 |
A-7715 |
1EA |
|
Atazanavir related compound A N-甲氧羰基-L-叔亮氨酸 |
| 163521-19-5 |
V-213 |
1EA |
|
Vilazodone Carboxy Acid 5-(4-(4-(5-氰基-1H-吲哚-3-基)丁基)哌嗪-1-基)苯并呋喃-2-羧酸 |
| 163521-19-5 |
V-213 |
1EA |
|
Vilazodone Carboxy Acid 5-(4-(4-(5-氰基-1H-吲哚-3-基)丁基)哌嗪-1-基)苯并呋喃-2-羧酸 |
| 16606-55-6 |
T-02114 |
1EA |
|
Tenofovir Impurity 69 (R)-碳酸丙烯酯 |
| 168167-42-8 |
L-0314 |
1EA |
|
Lansoprazole EP Impurity F (Rabeprazole EP Impurity H) |
| 168167-42-8 |
R-206 |
1EA |
|
Rabeprazole EP Impurity H (Lansoprazole EP Impurity F) |
| 168828-81-7 |
L-076 |
1EA |
|
Benzyl 3-Fluoro-4-(4-morpholinyl)phenyl)carbamate (3-氟-4-吗啉-4-基苯基)氨基甲酸苄酯 |
| 168828-84-0 |
L-0711 |
1EA |
|
Linezolid Related Compound A (R)-5-(叠氮甲基)-3-[3-氟-4-(4-吗啉基)苯基]-2-唑烷酮 |
| 168828-84-0 |
L-0711 |
1EA |
|
Linezolid Related Compound A (R)-5-(叠氮甲基)-3-[3-氟-4-(4-吗啉基)苯基]-2-唑烷酮 |
| 168828-84-0 |
L-0711 |
1EA |
|
Linezolid Related Compound A (R)-5-(叠氮甲基)-3-[3-氟-4-(4-吗啉基)苯基]-2-唑烷酮 |
| 168828-89-5 |
L-0725 |
1EA |
|
Linezolid Desacetamide Phthalimide (R)-[N-3-(3'-氟-4'-吗啉基)苯基-2-氧代-5-噁唑烷基]甲基邻苯二甲酰亚胺 |
| 168828-89-5 |
L-0725 |
1EA |
|
Linezolid Desacetamide Phthalimide (R)-[N-3-(3'-氟-4'-吗啉基)苯基-2-氧代-5-噁唑烷基]甲基邻苯二甲酰亚胺 |
| 168828-89-5 |
L-0725 |
1EA |
|
Linezolid Desacetamide Phthalimide (R)-[N-3-(3'-氟-4'-吗啉基)苯基-2-氧代-5-噁唑烷基]甲基邻苯二甲酰亚胺 |
| 168828-89-5 |
L-0725 |
1EA |
|
Linezolid Desacetamide Phthalimide (R)-[N-3-(3'-氟-4'-吗啉基)苯基-2-氧代-5-噁唑烷基]甲基邻苯二甲酰亚胺 |
| 168828-90-8 |
L-0712 |
1EA |
|
Linezolid Related Compound C (S)-5-(胺甲基)-3-(3-氟-4-吗啉代苯基)恶唑啉-2-酮 |
| 168828-90-8 |
L-0712 |
1EA |
|
Linezolid Related Compound C (S)-5-(胺甲基)-3-(3-氟-4-吗啉代苯基)恶唑啉-2-酮 |
| 168828-90-8 |
L-0712 |
1EA |
|
Linezolid Related Compound C (S)-5-(胺甲基)-3-(3-氟-4-吗啉代苯基)恶唑啉-2-酮 |
| 16915-70-1 |
N-127001 |
1EA |
|
Nifursol 2-羟基-3,5-二硝基-N'-((5-硝基呋喃-2-基)亚甲基)苯甲酰肼 |
| 170985-84-9 |
P-38106 |
1EA |
|
Posaconazole Impurity 70 2-[(2S)-2-(苄氧基)亚丙基]肼甲醛 |
| 171482-05-6 |
A-3215 |
1EA |
|
Aprepitant Impurity 1 Enantiomer HCl (2R,3S)-2-((R)-1-(3,5-双(三氟甲基)苯基)-乙氧基)-3-(4-氟苯基)吗啉 盐酸盐 |
| 171482-05-6 |
A-3215 |
1EA |
|
Aprepitant Impurity 1 Enantiomer HCl (2R,3S)-2-((R)-1-(3,5-双(三氟甲基)苯基)-乙氧基)-3-(4-氟苯基)吗啉 盐酸盐 |
| 17360-11-1 |
T-144005 |
1EA |
|
Dinitro-L-Tyrosine (S)-2-氨基-3-(4-羟基-3,5-二硝基苯基)丙酸 |
| 17403-07-5 |
N-2712 |
1EA |
|
Naratriptan Impurity 3 3-(1-甲基-4-哌啶基)吲哚，97% |
| 1744-22-5 |
R-141 |
1EA |
|
Riluzole 2-氨基-6-(三氟甲氧基)苯并噻唑 |
| 174649-09-3 |
L-0720 |
1EA |
|
Linezolid Related Compound 1 (R)-(3-(3-氟-4-吗啉代苯基)-2-羰基恶唑啉-5-基)甲基 甲烷磺酸酯 |
| 174649-09-3 |
L-0720 |
1EA |
|
Linezolid Related Compound 1 (R)-(3-(3-氟-4-吗啉代苯基)-2-羰基恶唑啉-5-基)甲基 甲烷磺酸酯 |
| 174649-09-3 |
L-0720 |
1EA |
|
Linezolid Related Compound 1 (R)-(3-(3-氟-4-吗啉代苯基)-2-羰基恶唑啉-5-基)甲基 甲烷磺酸酯 |
| 174649-09-3 |
L-0720 |
1EA |
|
Linezolid Related Compound 1 (R)-(3-(3-氟-4-吗啉代苯基)-2-羰基恶唑啉-5-基)甲基 甲烷磺酸酯 |
| 174649-09-3 |
L-0720 |
1EA |
|
Linezolid Related Compound 1 (R)-(3-(3-氟-4-吗啉代苯基)-2-羰基恶唑啉-5-基)甲基 甲烷磺酸酯 |
| 1771-18-2 |
L-104008 |
1EA |
|
Levomepromazine Impurity 1 2-甲氧基吩噻嗪 |
| 177472-30-9 |
L-2310 |
1EA |
|
Levofloxacin EP Impurity H 左氧氟沙星相关物质C |
| 177472-30-9 |
L-2310 |
1EA |
|
Levofloxacin EP Impurity H 左氧氟沙星相关物质C |
| 177472-30-9 |
L-2310 |
1EA |
|
Levofloxacin EP Impurity H 左氧氟沙星相关物质C |
| 177834-92-3 |
E-121 |
1EA |
|
Eletriptan HBr (S)-3-((1-甲基吡咯烷-2-基)甲基)-5-(2-(苯磺酰基)乙基)-1H-吲哚 |
| 177834-92-3 |
E-121 |
1EA |
|
Eletriptan HBr (S)-3-((1-甲基吡咯烷-2-基)甲基)-5-(2-(苯磺酰基)乙基)-1H-吲哚 |
| 177834-92-3 |
E-122 |
1EA |
|
Eletriptan-d3 HBr |
| 177834-92-3 |
E-122 |
1EA |
|
Eletriptan-d3 HBr |
| 178312-62-4 |
M-208004 |
1EA |
|
Homomorpholine Hydrochloride 盐酸高吗啉, 98% |
| 178422-45-2 |
C-1129 |
1EA |
|
Cefdinir Impurity 4 |
| 178422-45-2 |
C-1129 |
1EA |
|
Cefdinir Impurity 4 |
| 178422-45-2 |
C-1129 |
1EA |
|
Cefdinir Impurity 4 |
| 1797884-12-8 |
P-2517 |
1EA |
|
Piroxicam Impurity 4 |
| 1797979-55-5 |
R-0814 |
1EA |
|
Rosiglitazone Impurity 1 罗格列酮杂质1 |
| 180384-57-0 |
T-105001 |
1EA |
|
Tezosentan N-(2-(2-(2H-四唑-5-基)吡啶-4-基)-6-(2-羟基乙氧基)-5-(2-甲氧基苯氧基)嘧啶-4-基)-5-异丙基吡啶-2-磺酰胺 |
| 18156-74-6 |
I-078011 |
1EA |
|
1-(Trimethylsilyl)imidazole 三甲基硅咪唑，98% |
| 18156-74-6 |
I-078011 |
1EA |
|
1-(Trimethylsilyl)imidazole 三甲基硅咪唑，98% |
| 184177-83-1 |
P-3889 |
1EA |
|
Posaconazole Impurity 63 1-((2S,3S)-2-(苄氧基)戊烷-3-基)-4-(4-(4-(4-羟基苯基)-哌嗪-1-基)苯基)-1H-1,2,4-三唑-5(4H)-酮 |
| 184475-35-2 |
G-231 |
1EA |
|
Gefitinib 吉非替尼 |
| 185964-60-7 |
P-208011 |
1EA |
|
1-Methyl-2-Pyrrolidone-d9 氘代 1-甲基-2-吡咯烷酮-d{9}, 97%(同位素) |
| 185964-60-7 |
P-208011 |
1EA |
|
1-Methyl-2-Pyrrolidone-d9 氘代 1-甲基-2-吡咯烷酮-d{9}, 97%(同位素) |
| 188112-75-6 |
A-238 |
1EA |
|
Amoxicillin EP Impurity G Amoxicillin Related Compound G United States Pharmacopeia (USP) Reference Standard |
| 191864-24-1 |
Z-0222 |
1EA |
|
Zolmitriptan Impurity 14 Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard |
| 191864-24-1 |
Z-0222 |
1EA |
|
Zolmitriptan Impurity 14 Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard |
| 191864-24-1 |
Z-0222 |
1EA |
|
Zolmitriptan Impurity 14 Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard |
| 191864-24-1 |
Z-0222 |
1EA |
|
Zolmitriptan Impurity 14 Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard |
| 191864-24-1 |
Z-0222 |
1EA |
|
Zolmitriptan Impurity 14 Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard |
| 191864-24-1 |
Z-0222 |
1EA |
|
Zolmitriptan Impurity 14 Zolmitriptan Related Compound D United States Pharmacopeia (USP) Reference Standard |
| 192725-17-0 |
L-301 |
1EA |
|
Lopinavir 洛匹那韦 |
| 192726-05-9 |
L-3010 |
1EA |
|
Lopinavir EP Impurity A 洛匹那韦EP杂质A |
| 19685-09-7 |
C-735 |
1EA |
|
10-Hydroxy Camptothecin (Irinotecan EP Impurity B) (S)-4-乙基-4,9-二羟基-1H-吡喃并[3',4':6,7]吲嗪并[1,2-b]喹啉-3,14-(4H,12H)-二酮 |
| 19869-42-2 |
A-6829 |
1EA |
|
Azelastine Impurity 14 1-甲基六氢氮杂卓-4-酮盐酸盐 |
| 198904-85-7 |
A-7721 |
1EA |
|
Atazanavir Impurity 19 2-[4-(2-吡啶基)苄基]-肼羧酸叔丁酯 |
| 199327-61-2 |
G-2328 |
1EA |
|
Gefitinib Impurity 5 7-甲氧基-6-(3-吗啉-4-基丙氧基)喹唑啉-4(3H)-酮 |
| 20289-26-3 |
T-2027 |
1EA |
|
4-Benzyloxyindole 4-苄氧基吲哚 |
| 2080-75-3 |
O-0241 |
1EA |
|
Esomeprazole Impurity 4 (5-Methoxy-1, 3-Dihydro-benzoimidazol-2-One) 5-甲氧基-2-苯并咪唑啉酮, 98% |
| 209414-26-6 |
E-0735 |
1EA |
|
Efavirenz Impurity 13 (Mixture of Diastereomers) |
| 211364-69-1 |
T-0212 |
1EA |
|
Tenofovir Disoproxil Related Compound E 单POC泰诺福韦(非对映体的混合物) |
| 211364-69-1 |
T-0212 |
1EA |
|
Tenofovir Disoproxil Related Compound E 单POC泰诺福韦(非对映体的混合物) |
| 2149-70-4 |
A-9230 |
1EA |
|
N'-Nitro-L-Arginine Nω-硝基-L-精氨酸 |
| 21679-14-1 |
F-587 |
1EA |
|
Fludarabine (Fludarabine Phosphate EP Impurity E) (2R,3S,4S,5R)-2-(6-氨基-2-氟-9H-嘌呤-9-基)-5-(羟甲基)四氢呋喃-3,4-二醇 |
| 216854-23-8 |
A-4940 |
1EA |
|
Alogliptin Impurity 5 (S)-3-(Boc-氨基)哌啶,97% |
| 216854-23-8 |
A-4940 |
1EA |
|
Alogliptin Impurity 5 (S)-3-(Boc-氨基)哌啶,97% |
| 21732-17-2 |
C-9610 |
1EA |
|
Cefazolin Impurity 10 四氮唑乙酸 |
| 2188-18-3 |
A-9232 |
1EA |
|
Boc-L-Arg(NO2)-OH Boc-硝基-L-精氨酸 |
| 219861-53-7 |
C-094 |
1EA |
|
Escitalopram EP Impurity K Oxalate ((R)-Citalopram Oxalate) |
| 220127-57-1 |
I-097 |
1EA |
|
Imatinib Mesylate 甲磺酸伊马替尼 |
| 22204-53-1 |
N-235 |
1EA |
|
Naproxen (S)-(+)-2-(6-甲氧基-2-萘基)丙酸 |
| 225648-21-5 |
R-0122 |
1EA |
|
Raloxifene Impurity 8 2-(4-甲氧基苯基)苯并噻吩-6-醇 |
| 22818-40-2 |
A-2310 |
1EA |
|
Amoxicillin EP Impurity I D-(-)-4-羟基苯甘氨酸 |
| 22818-40-2 |
A-2310 |
1EA |
|
Amoxicillin EP Impurity I D-(-)-4-羟基苯甘氨酸 |
| 22818-40-2 |
C-7810 |
1EA |
|
Cefoperazone Impurity 3 D-(-)-4-羟基苯甘氨酸 |
| 22818-40-2 |
C-7810 |
1EA |
|
Cefoperazone Impurity 3 D-(-)-4-羟基苯甘氨酸 |
| 231278-84-5 |
L-2510 |
1EA |
|
Lapatinib Impurity 9 5-(4-((3-氯-4-((3-氟苄基)氧基)苯基)-氨)喹唑啉-6-基)呋喃-2-甲醛 |
| 231278-84-5 |
L-2510 |
1EA |
|
Lapatinib Impurity 9 5-(4-((3-氯-4-((3-氟苄基)氧基)苯基)-氨)喹唑啉-6-基)呋喃-2-甲醛 |
| 2349-67-9 |
A-3510 |
1EA |
|
Acetazolamide EP Impurity G 2-氨基-5-巯基-1,3,4-噻二唑 |
| 23491-52-3 |
H-066001 |
1EA |
|
Hoechst 33342 苯甲酰亚胺 |
| 23491-52-3 |
H-066001 |
1EA |
|
Hoechst 33342 苯甲酰亚胺 |
| 24155-42-8 |
I-292 |
1EA |
|
Isoconazole Nitrate EP Impurity A (Fenticonazole EP Impurity A, Econazole EP Impurity A) 1-(2,4-二氯苯基)-2-(1-咪唑基)乙醇 |
| 24155-42-8 |
M-7314 |
1EA |
|
Miconazole Nitrate Impurity A 1-(2,4-二氯苯基)-2-(1-咪唑基)乙醇 |
| 24683-26-9 |
M-025 |
1EA |
|
Meloxicam EP Impurity A 4-羟基-2-甲基-2H-1,2-苯并噻嗪-3-甲酸乙酯 1,1-二氧化物 |
| 24683-26-9 |
M-025 |
25mg |
|
Meloxicam EP Impurity A 4-羟基-2-甲基-2H-1,2-苯并噻嗪-3-甲酸乙酯 1,1-二氧化物 |
| 252638-01-0 |
L-422 |
1EA |
|
Levosimendan Impurity (2-[2-[4-(2-Azidotetrahydro-3-Methyl-5-oxo-2-Furanyl)phenyl]hydrazinylidene]propanedinitrile) 2- [2- [4-（2-叠氮基四氢-3-甲基-5-氧代-2-呋喃基）苯基]苯二亚甲基]丙腈（非对映异构体混合物） |
| 25333-42-0 |
S-1831 |
1EA |
|
Solifenacin EP Impurity E (R)-(-)-3-奎宁醇 |
| 25333-42-0 |
S-1831 |
1EA |
|
Solifenacin EP Impurity E (R)-(-)-3-奎宁醇 |
| 2592-95-2 |
O-032035 |
1EA |
|
1-Hydroxybenzotriazole (HOBT) |
| 260-94-6 |
A-141001 |
1EA |
|
Acridine 吖啶 |
| 26675-76-3 |
M-1629 |
1EA |
|
Mycophenolate Mofetil EP Impurity H (Mycophenolate Mofetil USP Related Compound B) 霉酚酸酯EP杂质H(霉酚酸酯-USP相关化合物B) |
| 26675-76-3 |
M-1629 |
1EA |
|
Mycophenolate Mofetil EP Impurity H (Mycophenolate Mofetil USP Related Compound B) 霉酚酸酯EP杂质H(霉酚酸酯-USP相关化合物B) |
| 2689-39-6 |
L-0746 |
1EA |
|
Linezolid Impurity 27 4-(2-氟-4-硝基苯基)吗啉 |
| 271-89-6 |
B-104001 |
1EA |
|
Benzofuran 2,3-苯并呋喃 |
| 27262-40-4 |
R-224 |
1EA |
|
Ropivacaine EP Impurity B (S).N-(2,6-二甲苯基)-2-哌啶甲酰胺 |
| 27387-31-1 |
O-0311 |
1EA |
|
Ondansetron EP Impurity C (Ondansetron USP Related Compound C) 1,2,3,9-四氢-9-甲基-4H-咔唑-4-酮 |
| 2788-28-5 |
L-865 |
1EA |
|
L-Carnitinenitrile Chloride L-卡内腈 |
| 28416-82-2 |
F-0937 |
1EA |
|
Fluticasone 17-beta-Carboxylic Acid (6a,9a,11b,16a,17a)-6,9-二氟-11,17-二羟基-16-甲基-3-羰基雄-1,4-二烯-17-羧酸 |
| 288-94-8 |
C-185018 |
1EA |
|
Ceftezole Impurity 17 四氮唑，3%-4%乙腈溶液 |
| 288-94-8 |
C-185018 |
1EA |
|
Ceftezole Impurity 17 四氮唑，3%-4%乙腈溶液 |
| 288-94-8 |
C-185018 |
1EA |
|
Ceftezole Impurity 17 四氮唑，3%-4%乙腈溶液 |
| 291536-42-0 |
R-0811 |
1EA |
|
Rosiglitazone Impurity (5-(4-Fluorobenzyl)-2,4-thiazolidinedione) 5-(4-氟苄基)噻唑烷-2,4-二酮 |
| 29169-64-0 |
C-162013 |
1EA |
|
Cefamandole Impurity 6 O-甲酰基-D-扁桃酰氯 |
| 29490-19-5 |
C-969 |
1EA |
|
Cefazolin EP Impurity E 5-甲基-1,3,4-噻二唑-2-硫醇 |
| 30165-96-9 |
T-686 |
1EA |
|
Timolol EP Impurity F 3-氯-4-吗啉基-1,2,5-噻二唑 |
| 30165-96-9 |
T-686 |
1EA |
|
Timolol EP Impurity F 3-氯-4-吗啉基-1,2,5-噻二唑 |
| 302964-08-5 |
D-308 |
1EA |
|
Dasatinib Impurity 3 2-((6-氯-2-甲基嘧啶-4-基)胺)-N-(2-氯-6-甲苯基)噻唑-5-甲酰胺 |
| 303-26-4 |
C-208 |
1EA |
|
Cetirizine EP Impurity A 1-(4-氯二苯甲基)哌嗪 |
| 3034-38-6 |
M-637 |
1EA |
|
Metronidazole EP Impurity B (4-Nitroimidazole) 4-硝基咪唑 |
| 309-29-5 |
D-142003 |
1EA |
|
Doxapram 1-乙基-4-(2-吗啉基乙)-3,3-二苯基吡咯烷-2-酮 |
| 312637-48-2 |
T-188001 |
1EA |
|
THIQ (R)-N-((R)-1-(4-((1H-1,2,4-三唑-1-基)甲基)-4-环己基哌啶-1-基)-3-(4-氯苯基 )-1-氧代丙-2-基)-1,2,3,4-四氢异喹啉-3-甲酰胺 |
| 312637-48-2 |
T-188002 |
1EA |
|
THIQ-d7 |
| 314771-76-1 |
A-111005 |
1EA |
|
Afatinib Impurity B (S)-N4-(3-氯-4-氟苯基)-7-((四氢呋喃-3-基)氧基)喹唑啉-4,6-二胺 |
| 314771-76-1 |
A-111005 |
1EA |
|
Afatinib Impurity B (S)-N4-(3-氯-4-氟苯基)-7-((四氢呋喃-3-基)氧基)喹唑啉-4,6-二胺 |
| 3181-38-2 |
R-0426 |
1EA |
|
Ribavirin Impurity 14 (Triacetylinosine) (2R,3R,4R,5R)-2-(乙酰氧基甲基)-5-(6-羰基-1H-嘌呤-9(6H)-基)四氢呋喃-3,4-二基 二乙酸酯 |
| 31828-68-9 |
C-7731 |
1EA |
|
L-Homocysteine Thiolactone HCl (S)-3-氨二氢噻吩-2(3H)-酮 盐酸盐 |
| 31828-68-9 |
C-7731 |
1EA |
|
L-Homocysteine Thiolactone HCl (S)-3-氨二氢噻吩-2(3H)-酮 盐酸盐 |
| 319460-85-0 |
A-188008 |
1EA |
|
Axitinib (E)-N-甲基-2-((3-(2-(吡啶-2-基)乙烯基)-1H-吲唑-6-基)硫代)苯甲酰胺 |
| 320345-99-1 |
A-211002 |
1EA |
|
Aclidinium Bromide (3R)-3-(2-羟基-2,2-二(噻吩-2-基)乙酰氧基)-1-(3-苯氧基丙基)喹宁环-1-鎓 溴化物 |
| 320345-99-1 |
A-211002 |
1EA |
|
Aclidinium Bromide (3R)-3-(2-羟基-2,2-二(噻吩-2-基)乙酰氧基)-1-(3-苯氧基丙基)喹宁环-1-鎓 溴化物 |
| 32093-35-9 |
L-901 |
1EA |
|
Levamisole Phosphate (S)-6-苯基-2,3,5,6-四氢咪唑并-[2,1-b]噻唑 磷酸酯 |
| 32093-35-9 |
L-901 |
1EA |
|
Levamisole Phosphate (S)-6-苯基-2,3,5,6-四氢咪唑并-[2,1-b]噻唑 磷酸酯 |
| 32093-35-9 |
L-901 |
1EA |
|
Levamisole Phosphate (S)-6-苯基-2,3,5,6-四氢咪唑并-[2,1-b]噻唑 磷酸酯 |
| 32503-27-8 |
F-106051 |
1EA |
|
Tetrabutylammonium Hydrogen Sulfate 四丁基硫酸氢铵(98%) |
| 328385-86-0 |
L-0810 |
1EA |
|
Lisinopril EP Impurity C HCl ((S,S,S)-Diketopiperazine HCl) (2S)-2-[(3S,8AS)-3-(4-氨基丁基)-1,4-二氧代六氢吡咯并[1,2-A]吡嗪-2(H)-基]-4-苯基丁酸 |
| 334618-23-4 |
A-4954 |
1EA |
|
Alogliptin Impurity 18 DiHCl (R)-(-)-3-氨基哌啶二盐酸盐, 98% |
| 344-25-2 |
P-166017 |
1EA |
|
D-Proline D-脯氨酸 |
| 34592-47-7 |
P-136007 |
1EA |
|
Pidotimod Impurity 1 (L-Thioproline) L-硫代脯氨酸 |
| 34592-47-7 |
P-136007 |
1EA |
|
Pidotimod Impurity 1 (L-Thioproline) L-硫代脯氨酸 |
| 34592-47-7 |
P-136007 |
1EA |
|
Pidotimod Impurity 1 (L-Thioproline) L-硫代脯氨酸 |
| 35212-22-7 |
I-087001 |
1EA |
|
Ipriflavone 依普黄酮 |
| 3533-97-9 |
P-203 |
1EA |
|
Perphenazine Related Compound B 奋乃静相关物质B |
| 3533-97-9 |
P-203 |
1EA |
|
Perphenazine Related Compound B 奋乃静相关物质B |
| 35661-60-0 |
L-117005 |
1EA |
|
Fmoc-Leu-OH N-[(9H-芴-9-基甲氧基)羰基]-L-亮氨酸 |
| 360-97-4 |
D-090005 |
1EA |
|
4-Amino-5-Imidazolecarboxamide-13C3-15N |
| 3607-17-8 |
O-1023 |
1EA |
|
Olopatadine Impurity 7 3-溴丙基三苯基溴化磷 |
| 366789-02-8 |
R-291 |
1EA |
|
Rivaroxaban (S)-5-氯-N-((2-羰基-3-(4-(3-羰基吗啉代)苯基)-恶唑啉-5-基)甲基)噻吩-2-甲酰胺 |
| 366789-02-8 |
R-291 |
1EA |
|
Rivaroxaban (S)-5-氯-N-((2-羰基-3-(4-(3-羰基吗啉代)苯基)-恶唑啉-5-基)甲基)噻吩-2-甲酰胺 |
| 366789-02-8 |
R-291 |
1EA |
|
Rivaroxaban (S)-5-氯-N-((2-羰基-3-(4-(3-羰基吗啉代)苯基)-恶唑啉-5-基)甲基)噻吩-2-甲酰胺 |
| 368890-20-4 |
P-0164 |
1EA |
|
Pantoprazole Impurity 43 5-(二氟甲氧基)-2-{[(4-氯-3-甲氧基-2-吡啶基)甲基]硫}-1H-苯并咪唑 |
| 368890-20-4 |
P-0164 |
1EA |
|
Pantoprazole Impurity 43 5-(二氟甲氧基)-2-{[(4-氯-3-甲氧基-2-吡啶基)甲基]硫}-1H-苯并咪唑 |
| 3705-27-9 |
V-2237 |
1EA |
|
Vildagliptin Impurity 26 (S)-六氢吡咯并[1,2-a]吡嗪-1,4-二酮 |
| 37052-78-1 |
O-0232 |
1EA |
|
Omeprazole EP Impurity A (5-Methoxy-1H-Benzimidazole-2-Thiol) 5-甲氧基-2-苯并咪唑硫醇 |
| 37052-78-1 |
O-0232 |
1EA |
|
Omeprazole EP Impurity A (5-Methoxy-1H-Benzimidazole-2-Thiol) 5-甲氧基-2-苯并咪唑硫醇 |
| 37743-18-3 |
L-096 |
1EA |
|
Loperamide Impurity (3,3-二苯基二氢呋喃-2-取代基)-二甲基铵 溴化物 |
| 37763-23-8 |
C-135012 |
1EA |
|
Cefadroxil Impurity 1 (Methyl(2R)-2-Amino-2-(4-Hydroxyphenyl)acetate) 甲基 D-(-)-4-羟基苯基甘氨酸酯 |
| 37763-23-8 |
C-135012 |
1EA |
|
Cefadroxil Impurity 1 (Methyl(2R)-2-Amino-2-(4-Hydroxyphenyl)acetate) 甲基 D-(-)-4-羟基苯基甘氨酸酯 |
| 38585-74-9 |
R-2734 |
1EA |
|
Ritonavir Impurity 17 5-羟甲基噻唑 |
| 3886-69-9 |
B-112001 |
1EA |
|
(R)-alfa-Methylbenzylamine ((R)-1-Phenylethylamine) D(+)-α-苯乙胺 |
| 391210-10-9 |
PF-0003 |
1EA |
|
PD 0325901 (R)-N-(2,3-二羟基丙氧基)-3,4-二氟-2-(2-氟-4-碘苯基胺)苯甲酰胺 |
| 39746-01-5 |
T-106030 |
1EA |
|
Travoprost Impurity 16 [3aR(3aα,4α,5β,6aα)]-(-)-5-(苯甲酰氧基)六氢-2-氧代-2H-环戊并[b]呋喃-4-甲醛 |
| 39890-45-4 |
C-143006 |
1EA |
|
Cinepazide Impurity 5 1-(2-羰基-2-吡咯烷-1-基乙基)哌嗪 |
| 40371-51-5 |
A-144009 |
1EA |
|
Amikacin EP Impurity I (S)-(-)-4-氨基-2-羟基丁酸 |
| 4137-56-8 |
C-3547 |
1EA |
|
Capecitabine Impurity 33 1-甲氧基-2,3-O-异亚丙基-5-O |
| 41944-01-8 |
B-151 |
1EA |
|
Bismuth Potassium Iodide 碘化铋钾 |
| 41944-01-8 |
B-151 |
1EA |
|
Bismuth Potassium Iodide 碘化铋钾 |
| 41944-01-8 |
B-151 |
1EA |
|
Bismuth Potassium Iodide 碘化铋钾 |
| 41944-01-8 |
B-151 |
1EA |
|
Bismuth Potassium Iodide 碘化铋钾 |
| 4205-91-8 |
C-258 |
1EA |
|
Clonidine HCl 2-(2,6-二氯苯胺基)-2-咪唑啉盐酸盐 |
| 42288-26-6 |
D-5965 |
1EA |
|
Dabigatran Impurity 33 N-4-苯腈甘氨酸 |
| 42538-31-8 |
O-262 |
1EA |
|
Ornithine-1,5-Lactam HCl (S)-3-氨基-2-哌啶酮盐酸盐 |
| 4265-07-0 |
P-10206 |
1EA |
|
Phospho(enol)pyruvic acid monopotassium salt 磷酸烯醇丙酮酸酯一钾, 99% |
| 4265-07-0 |
P-10206 |
1EA |
|
Phospho(enol)pyruvic acid monopotassium salt 磷酸烯醇丙酮酸酯一钾, 99% |
| 435273-75-9 |
I-065009 |
1EA |
|
Indacaterol Impurity 7 茚达特罗杂质7对照品 |
| 438056-69-0 |
R-2953 |
1EA |
|
Rivaroxaban Impurity 37 4-(4-氨基苯基)吗啉-3-酮 |
| 440124-96-9 |
E-074 |
1EA |
|
Efavirenz USP Related Compound B |
| 440124-96-9 |
E-074 |
1EA |
|
Efavirenz USP Related Compound B |
| 443-48-1 |
M-6313 |
1EA |
|
Metronidazole 甲硝唑 |
| 444335-16-4 |
T-163010 |
1EA |
|
Tedizolid Impurity 9 (R)-3-(4-溴-3-氟苯基)-5-(羟甲基)恶唑啉-2-酮 |
| 444335-16-4 |
T-163010 |
1EA |
|
Tedizolid Impurity 9 (R)-3-(4-溴-3-氟苯基)-5-(羟甲基)恶唑啉-2-酮 |
| 444731-52-6 |
P-129001 |
1EA |
|
Pazopanib 5-[4-[(2,3-二甲基-2H-吲唑-6-基)-甲基-胺]-嘧啶-2-基胺]-2-甲基-苯磺酰胺 |
| 444731-74-2 |
P-129015 |
1EA |
|
Pazopanib Impurity 6 N-(2-氯嘧啶-4-基)-2,3-二甲基-2H-吲唑-6-胺 |
| 444731-75-3 |
P-129017 |
1EA |
|
Pazopanib Impurity 8 6-[N-(2-氯-4-嘧啶基)甲基氨基]-2,3-二甲基-2H-吲唑, 96% |
| 446292-04-2 |
R-2968 |
1EA |
|
Rivaroxaban Impurity 52 4-(4-硝基苯基)吗啉-3-酮 |
| 446292-07-5 |
R-2965 |
1EA |
|
Rivaroxaban Impurity 50 2-[(2R)-2-羟基-3-[[4-(3-氧代-4-吗啉基)苯基]氨基]丙基]-1H-异吲哚-1,3(2H)-二酮 |
| 446292-07-5 |
R-2965 |
1EA |
|
Rivaroxaban Impurity 50 2-[(2R)-2-羟基-3-[[4-(3-氧代-4-吗啉基)苯基]氨基]丙基]-1H-异吲哚-1,3(2H)-二酮 |
| 446292-07-5 |
R-2965 |
1EA |
|
Rivaroxaban Impurity 50 2-[(2R)-2-羟基-3-[[4-(3-氧代-4-吗啉基)苯基]氨基]丙基]-1H-异吲哚-1,3(2H)-二酮 |
| 446292-07-5 |
R-2965 |
1EA |
|
Rivaroxaban Impurity 50 2-[(2R)-2-羟基-3-[[4-(3-氧代-4-吗啉基)苯基]氨基]丙基]-1H-异吲哚-1,3(2H)-二酮 |
| 446292-08-6 |
R-2915 |
1EA |
|
Rivaroxaban Impurity 9 (S)-2-((2-羰基-3-(4-(3-羰基吗啉代)苯基)-恶唑啉-5-基)甲基)异吲哚林-1,3-二酮 |
| 446292-08-6 |
R-2915 |
1EA |
|
Rivaroxaban Impurity 9 (S)-2-((2-羰基-3-(4-(3-羰基吗啉代)苯基)-恶唑啉-5-基)甲基)异吲哚林-1,3-二酮 |
| 446292-08-6 |
R-2915 |
1EA |
|
Rivaroxaban Impurity 9 (S)-2-((2-羰基-3-(4-(3-羰基吗啉代)苯基)-恶唑啉-5-基)甲基)异吲哚林-1,3-二酮 |
| 446292-08-6 |
R-2915 |
1EA |
|
Rivaroxaban Impurity 9 (S)-2-((2-羰基-3-(4-(3-羰基吗啉代)苯基)-恶唑啉-5-基)甲基)异吲哚林-1,3-二酮 |
| 446292-08-6 |
R-2915 |
1EA |
|
Rivaroxaban Impurity 9 (S)-2-((2-羰基-3-(4-(3-羰基吗啉代)苯基)-恶唑啉-5-基)甲基)异吲哚林-1,3-二酮 |
| 446292-08-6 |
R-2915 |
1EA |
|
Rivaroxaban Impurity 9 (S)-2-((2-羰基-3-(4-(3-羰基吗啉代)苯基)-恶唑啉-5-基)甲基)异吲哚林-1,3-二酮 |
| 4498-67-3 |
G-079 |
1EA |
|
Granisetron EP Impurity H 吲唑-3-甲酸 |
| 4857-06-1 |
E-349 |
1EA |
|
Emedastine Related Compound 1 |
| 486460-00-8 |
S-2025 |
1EA |
|
Sitagliptin Impurity 19 ((R)-Sitagliptin N-Boc-Acid Impurity) Boc-(R)-3-氨基-4-(2,4,5-三氟苯基)丁酸 |
| 486460-00-8 |
S-2025 |
1EA |
|
Sitagliptin Impurity 19 ((R)-Sitagliptin N-Boc-Acid Impurity) Boc-(R)-3-氨基-4-(2,4,5-三氟苯基)丁酸 |
| 488787-59-3 |
C-0917 |
1EA |
|
Citalopram Impurity 15 (S)-4-(4-(二甲氨基)-1-(4-氟苯基)-1-羟基丁基)-3-(羟甲基)苯甲腈 |
| 4897-25-0 |
P-138002 |
1EA |
|
5-Chloro-1-Methyl-4-Nitroimidazole 5-氯-1-甲基-4-硝基咪唑 |
| 49559-83-3 |
O-0277 |
1EA |
|
Esomeprazole Impurity 24 5-甲氧基-1,3-苯并恶唑-2-硫醇 |
| 496031-57-3 |
L-0780 |
1EA |
|
Linezolid Impurity 62 (R)-5-(氯甲基)-3-(3-氟-4-吗啉代苯基)恶唑啉-2-酮 |
| 496031-57-3 |
L-0780 |
1EA |
|
Linezolid Impurity 62 (R)-5-(氯甲基)-3-(3-氟-4-吗啉代苯基)恶唑啉-2-酮 |
| 496031-57-3 |
L-0780 |
1EA |
|
Linezolid Impurity 62 (R)-5-(氯甲基)-3-(3-氟-4-吗啉代苯基)恶唑啉-2-酮 |
| 497-25-6 |
O-060001 |
1EA |
|
2-Oxazolidone 恶唑烷-2-酮 |
| 49761-82-2 |
M-6865 |
1EA |
|
Medetomidine Impurity 58 N-叔丁氧羰基咪唑 |
| 49761-82-2 |
M-6865 |
1EA |
|
Medetomidine Impurity 58 N-叔丁氧羰基咪唑 |
| 49761-82-2 |
M-6865 |
1EA |
|
Medetomidine Impurity 58 N-叔丁氧羰基咪唑 |
| 50-01-1 |
G-178004 |
1EA |
|
Guanidine HCl |
| 50890-83-0 |
G-0713 |
1EA |
|
Granisetron EP Impurity D 1-甲基吲唑-3-羧酸,97% |
| 50913-12-7 |
A-9233 |
1EA |
|
Boc-D-Arg(NO2)-OH Nalpha-Boc-Nomega-硝基-D-精氨酸 |
| 50913-12-7 |
A-9233 |
1EA |
|
Boc-D-Arg(NO2)-OH Nalpha-Boc-Nomega-硝基-D-精氨酸 |
| 51-35-4 |
P-166019 |
1EA |
|
trans-4-Hydroxy-L-Proline 反-4-羟基-L-脯氨酸 |
| 51298-62-5 |
A-5990 |
1EA |
|
Argatroban Impurity 75 HCl N-硝基-L-精氨酸甲酯盐酸盐 |
| 51298-62-5 |
A-5990 |
1EA |
|
Argatroban Impurity 75 HCl N-硝基-L-精氨酸甲酯盐酸盐 |
| 51323-05-8 |
T-0312 |
1EA |
|
Tizanidine EP Impurity B N-(5-氯-2,1,3-苯并噻二唑-4-基)硫脲 |
| 51446-62-9 |
G-3816 |
1EA |
|
L-alpha-Phosphatidyl-L-serine (2S)-2-氨基-3-((((R)-2,3-双(硬脂酸oyl氧基)丙氧基)-(羟基)磷酰基)氧基)丙酸 |
| 51446-62-9 |
G-3816 |
1EA |
|
L-alpha-Phosphatidyl-L-serine (2S)-2-氨基-3-((((R)-2,3-双(硬脂酸oyl氧基)丙氧基)-(羟基)磷酰基)氧基)丙酸 |
| 51594-55-9 |
E-082002 |
1EA |
|
(R)-Epichlorohydrin (R)-(-)-环氧氯丙烷 |
| 52602-39-8 |
C-324003 |
1EA |
|
4-Hydroxy Carbazole 4-羟基咔唑 |
| 530-62-1 |
I-078006 |
1EA |
|
1,1'-Carbonyldiimidazole 1，1-羰基二咪唑 |
| 530084-79-8 |
I-065018 |
1EA |
|
Indacaterol Impurity 14 (R)-8-(苄氧基)-5-(2-溴-1-羟乙基)-喹啉-2(1H)-酮 |
| 530084-79-8 |
I-065018 |
1EA |
|
Indacaterol Impurity 14 (R)-8-(苄氧基)-5-(2-溴-1-羟乙基)-喹啉-2(1H)-酮 |
| 53786-28-0 |
D-493 |
1EA |
|
Domperidone EP Impurity A 5-氯-1-(4-哌啶子基)-2-苯并咪唑烷酮, 98% |
| 53872-60-9 |
T-106027 |
1EA |
|
Travoprost Impurity 13 (+)-(3AR,4R,5R,6AS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-4-(3-三氟甲基)苯氧基-1-丁烯基]-2H-环戊并[B]呋喃-2-酮 |
| 53872-60-9 |
T-106027 |
1EA |
|
Travoprost Impurity 13 (+)-(3AR,4R,5R,6AS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-4-(3-三氟甲基)苯氧基-1-丁烯基]-2H-环戊并[B]呋喃-2-酮 |
| 54-16-0 |
T-208 |
1EA |
|
Tryptophan Metabolite (HIAA) 5-羟基吲哚-3-乙酸 1GR |
| 54-47-7 |
P-716 |
1EA |
|
Pyridoxal 5-Phosphate 磷酸吡哆醛 |
| 5464-78-8 |
U-0711 |
1EA |
|
Urapidil Impurity 6 HCl 1-(2-甲氧苯基)哌嗪 盐酸盐,97% |
| 5464-78-8 |
U-0711 |
100mg |
|
Urapidil Impurity 6 HCl 1-(2-甲氧苯基)哌嗪 盐酸盐,97% |
| 5465-96-3 |
I-117003 |
1EA |
|
Imidacloprid Impurity 1 2-硝基氨基-2-咪唑啉 |
| 55745-83-0 |
L-090047 |
1EA |
|
Lurasidone Impurity 35 2-(1-哌嗪基)苯并噻唑 |
| 55745-83-0 |
L-090047 |
1EA |
|
Lurasidone Impurity 35 2-(1-哌嗪基)苯并噻唑 |
| 55750-06-6 |
I-261 |
1EA |
|
Imidocarb Dipropionate 咪多卡二丙酸盐 |
| 56038-13-2 |
S-053003 |
1EA |
|
Sucralose |
| 56341-37-8 |
I-128006 |
1EA |
|
6-chloroindolin-2-one 6-氯羟基吲哚 |
| 56341-41-4 |
S-4118 |
1EA |
|
5-Fluoro-1,3-dihydro-2H-indol-2-one 5-氟吲哚酮 |
| 56516-72-4 |
A-233007 |
1EA |
|
N-Nitroso-Glyphosate |
| 56610-72-1 |
C-167020 |
1EA |
|
Cefminox Sodium Impurity 19 7-MAC |
| 569-31-3 |
N-061005 |
1EA |
|
Noscapine Impurity 4 (Meconine) 6,7-二甲氧基-3H-1-异苯并呋喃酮 |
| 57090-45-6 |
E-082008 |
1EA |
|
Epichlorohydrin Impurity 6 (R)-(-)-3-氯-1,2-丙二醇 |
| 571188-59-5 |
R-128007 |
1EA |
|
Ribociclib Related Compound 1 4-(6-氨基-3-吡啶基)-1-Boc-哌嗪, 97% |
| 571188-59-5 |
R-128007 |
1EA |
|
Ribociclib Related Compound 1 4-(6-氨基-3-吡啶基)-1-Boc-哌嗪, 97% |
| 5718-83-2 |
E-6017 |
1EA |
|
Epalrestat Impurity 10 (Rhodanine-3-acetic Acid) 绕丹宁-3-乙酸 |
| 572-09-8 |
R-079032 |
1EA |
|
Rhapontin 乙酰溴-alpha-D-葡萄糖, 2% 碳酸钙作为稳定剂 |
| 57260-71-6 |
O-032009 |
1EA |
|
Olaparib Impurity 7 1-Boc-哌嗪 |
| 57260-71-6 |
O-032009 |
1EA |
|
Olaparib Impurity 7 1-Boc-哌嗪 |
| 57260-71-6 |
O-032009 |
1EA |
|
Olaparib Impurity 7 1-Boc-哌嗪 |
| 57260-71-6 |
O-032009 |
1EA |
|
Olaparib Impurity 7 1-Boc-哌嗪 |
| 573691-09-5 |
A-145 |
1EA |
|
Aripiprazole EP Impurity F (Aripiprazole N-Oxide) |
| 58970-76-6 |
B-119001 |
1EA |
|
Bestatin (Ubenimex) N-[(2S，3R)-3-氨基-2-羟基-4-苯丁酰]-L-亮氨酸 |
| 58970-76-6 |
B-119002 |
1EA |
|
Bestatin-d5 (Ubenimex-d5) |
| 59-48-3 |
D-069 |
1EA |
|
Diclofenac EP Impurity E (Oxindole) 2-吲哚酮,97+% |
| 59-89-2 |
M-208006 |
1EA |
|
N-Nitrosomorpholine N-亚硝基吗啉 |
| 5904-70-1 |
N-4716 |
1EA |
|
Nifuratel Impurity 13 硝呋太尔杂质 |
| 591-01-5 |
M-4210 |
1EA |
|
Metformin Impurity 2 Hemi-Sulfate N-硫酸脒基脲 |
| 59803-98-4 |
B-162 |
1EA |
|
Brimonidine 溴莫尼定 |
| 59804-25-0 |
T-130006 |
1EA |
|
Tenoxicam EP Impurity B 2-甲基-4-羟基-2H-噻吩并[2,3-e]-1,2-噻嗪-3-甲酸甲酯-1,1-二氧化物 |
| 59804-37-4 |
T-130005 |
1EA |
|
Tenoxicam 替诺昔康 |
| 59804-37-4 |
T-130005 |
1EA |
|
Tenoxicam 替诺昔康 |
| 5987-73-5 |
A-106019 |
1EA |
|
Adenosine Related Compound 5 (2R,3R,4R,5R)-2-(乙酰氧基甲基)-5-(6-氯-9H-嘌呤-9-基)四氢呋喃-3,4-二基 二乙酸酯 |
| 608-07-1 |
M-769 |
1EA |
|
Melatonin USP Related Compound A 5-甲氧基色胺 |
| 611-71-2 |
S-0325 |
1EA |
|
Sertraline EP Impurity E ((R)-Mandelic Acid) (R)-(-)-扁桃酸 |
| 61260-15-9 |
O-032005 |
1EA |
|
Olaparib Impurity 3 二甲基 (3-羰基-1,3-二氢异苯并呋喃-1-基)磷酸酯 |
| 61260-15-9 |
O-032005 |
1EA |
|
Olaparib Impurity 3 二甲基 (3-羰基-1,3-二氢异苯并呋喃-1-基)磷酸酯 |
| 616-47-7 |
M-442 |
1EA |
|
Methimazole (Thiamazole) Impurity B 1-甲基咪唑 |
| 61607-68-9 |
C-10321 |
1EA |
|
Cefotiam Impurity 17 1-(2-二甲基氨基乙基)-1H-5-巯基四唑 |
| 62211-93-2 |
C-3527 |
1EA |
|
Capecitabine Impurity 13 1,2,3-三-O-乙酰基-5-脱氧-beta-D-呋喃核糖 |
| 62780-89-6 |
D-499 |
1EA |
|
Domperidone Impurity 1 1-(3-氯丙基)-1,3-二氢-2H-苯并咪唑-2-酮 |
| 62893-24-7 |
C-789 |
1EA |
|
Cefoperazone Impurity 2 (R)-(-)-α-[[(4-乙基-2,3-二氧-1-哌嗪基)羰基]氨基]-4-羟基苯乙酸 |
| 62893-24-7 |
C-789 |
1EA |
|
Cefoperazone Impurity 2 (R)-(-)-α-[[(4-乙基-2,3-二氧-1-哌嗪基)羰基]氨基]-4-羟基苯乙酸 |
| 63-37-6 |
C-4538 |
1EA |
|
Cytidine 5'-Monophosphate 胞苷5'-单磷酸 |
| 63-37-6 |
C-4538 |
1EA |
|
Cytidine 5'-Monophosphate 胞苷5'-单磷酸 |
| 63422-71-9 |
P-747 |
1EA |
|
Piperacillin Sodium EP Impurity G (R)-(-)-α-[[(4-乙基-2,3-二氧-1-哌嗪基)羰基]氨基]苯乙酸 |
| 63422-71-9 |
P-747 |
1EA |
|
Piperacillin Sodium EP Impurity G (R)-(-)-α-[[(4-乙基-2,3-二氧-1-哌嗪基)羰基]氨基]苯乙酸 |
| 641571-10-0 |
N-311 |
1EA |
|
Nilotinib 尼罗替尼 |
| 6419-19-8 |
P-544 |
1EA |
|
Aminotrismethylenephosphonic Acid 次氮基三(亚甲基膦酸)(约5%的水溶液,约2.2mol/L) |
| 64211-06-9 |
O-123 |
1EA |
|
Oxiconazole Related Compound B (Z)-1-(2,4-二氯苯基)-2-(1H-咪唑-1-基)乙酮 肟 |
| 643764-88-9 |
R-0812 |
1EA |
|
Rosiglitazone Impurity (5-[4-N-(2-Pyridylamino)ethoxy]benzylidene] thiazolidine-2,4-dione) 罗格列酮杂质 |
| 64485-88-7 |
C-108023 |
1EA |
|
Cefazedone Impurity 20 (Z)-2-(2-氨基-4-噻唑基)-2-(甲氧基亚氨基)乙酸乙酯 |
| 645-12-5 |
N-4712 |
1EA |
|
Nifuratel Impurity 9 5-硝基-2-呋喃甲酸 |
| 65872-41-5 |
C-11110 |
1EA |
|
Cefepime EP Impurity D 2-氨基-alpha-(甲氧亚胺基)-4-噻唑乙酸 |
| 66357-40-2 |
R-0334 |
1EA |
|
Ranitidine Impurity 20 2-硝基亚甲基噻唑烷, 97% |
| 67-20-9 |
N-341 |
1EA |
|
Nitrofurantoin 呋喃妥英, 98% |
| 67-20-9 |
N-341 |
1EA |
|
Nitrofurantoin 呋喃妥英, 98% |
| 6722-09-4 |
P-110025 |
1EA |
|
Pranoprofen Impurity 22 普拉洛芬杂质22 |
| 675126-28-0 |
G-2344 |
1EA |
|
Gefitinib Impurity 24 3-(3-吗啉丙氧基)-4-甲氧基苄腈 |
| 6893-02-3 |
T-423 |
1EA |
|
Liothyronine 三碘甲状腺原氨酸 |
| 69056-38-8 |
S-311 |
1EA |
|
Sapropterin DiHCl (Dehydro Sepiapterin DiHCl) (R)-2-氨基-6-((1R,2S)-1,2-二羟基丙基)-5,6,7,8-四氢蝶啶-4(3H)-酮 二盐酸盐 |
| 69712-56-7 |
C-243001 |
1EA |
|
Cefotetan 头孢替坦 |
| 69712-56-7 |
C-243001 |
1EA |
|
Cefotetan 头孢替坦 |
| 70359-46-5 |
B-165 |
1EA |
|
Brimonidine D-Tartrate 溴莫尼定酒石酸盐 |
| 70374-39-9 |
L-351 |
1EA |
|
Lornoxicam 氯诺昔康 |
| 70415-50-8 |
L-3513 |
1EA |
|
Lornoxicam Impurity 12 6-氯-4-羟基-2-甲基-2H-噻吩并[2,3-e]-1,2-噻嗪-3-羧酸 甲基 酯 1,1-二氧 |
| 70918-74-0 |
D-149 |
1EA |
|
Doxazosin EP Impurity B N-[(1,4-苯并二噁烷-2-基)羰基]哌嗪盐酸盐 |
| 70918-74-0 |
D-149 |
1EA |
|
Doxazosin EP Impurity B N-[(1,4-苯并二噁烷-2-基)羰基]哌嗪盐酸盐 |
| 723286-98-4 |
S-2068 |
1EA |
|
Sitagliptin Impurity 30 5-氯甲基-2-三氟甲基-1,3,4-噁二唑 |
| 73-32-5 |
L-117001 |
1EA |
|
Isoleucine-13C L-异亮氨酸-13C |
| 73-32-5 |
L-117007 |
1EA |
|
L-Isoleucine L-异亮氨酸 |
| 73-32-5 |
L-117008 |
1EA |
|
L-Isoleucine-13C6-15N-d10 L-异亮氨酸-13C6-15N-d10 |
| 73963-62-9 |
C-0710 |
1EA |
|
3,4-Dehydro Cilostazol-d11 (Cilostazol USP related compound B-d11) |
| 73963-62-9 |
C-076 |
1EA |
|
Cilostazol Metabolite (OPC-13015) |
| 73963-72-1 |
C-071 |
1EA |
|
Cilostazol 西洛他唑 |
| 7440-23-5 |
A-192039 |
1EA |
|
Avibactam Impurity 38 (Sodium) 钠，3wt％分散在甲苯中，粒径<.1mm |
| 7440-23-5 |
A-192039 |
1EA |
|
Avibactam Impurity 38 (Sodium) 钠，3wt％分散在甲苯中，粒径<.1mm |
| 7440-23-5 |
A-192039 |
1EA |
|
Avibactam Impurity 38 (Sodium) 钠，3wt％分散在甲苯中，粒径<.1mm |
| 7440-23-5 |
A-192039 |
1EA |
|
Avibactam Impurity 38 (Sodium) 钠，3wt％分散在甲苯中，粒径<.1mm |
| 7440-23-5 |
A-192039 |
1EA |
|
Avibactam Impurity 38 (Sodium) 钠，3wt％分散在甲苯中，粒径<.1mm |
| 7440-23-5 |
A-192039 |
1EA |
|
Avibactam Impurity 38 (Sodium) 钠，3wt％分散在甲苯中，粒径<.1mm |
| 7440-23-5 |
A-192039 |
1EA |
|
Avibactam Impurity 38 (Sodium) 钠，3wt％分散在甲苯中，粒径<.1mm |
| 7440-23-5 |
A-192039 |
1EA |
|
Avibactam Impurity 38 (Sodium) 钠，3wt％分散在甲苯中，粒径<.1mm |
| 74772-78-4 |
P-1016 |
1EA |
|
Pioglitazone Metabolite M1 5-(4-羟基苄基)噻唑烷-2,4-二酮 |
| 74852-62-3 |
I-0348 |
1EA |
|
Itraconazole Impurity 23 1-(4-氨基苯基)-4-(4-甲氧基苯基)哌嗪 |
| 7664-38-2 |
P-835 |
1EA |
|
Phosphoric Acid 85%磷酸水溶液 |
| 76703-63-4 |
C-260007 |
1EA |
|
Cyhalothrin Impurity 5 |
| 76824-35-6 |
F-191 |
1EA |
|
Famotidine 法莫替丁 |
| 76824-35-6 |
F-193 |
1EA |
|
Famotidine-15N2-13C |
| 76855-69-1 |
F-087006 |
1EA |
|
4-AA ((2R,3R)-3-((R)-1-(tert-Butyldimethylsilyloxy)ethyl)-4-oxoazetidin-2-yl acetate) (3R,4R)-4-乙酰氧基-3-[(R)-叔丁基二甲硅氧基)乙基]-2-氮杂环丁酮 |
| 76855-69-1 |
F-087006 |
1EA |
|
4-AA ((2R,3R)-3-((R)-1-(tert-Butyldimethylsilyloxy)ethyl)-4-oxoazetidin-2-yl acetate) (3R,4R)-4-乙酰氧基-3-[(R)-叔丁基二甲硅氧基)乙基]-2-氮杂环丁酮 |
| 76855-69-1 |
F-087006 |
1EA |
|
4-AA ((2R,3R)-3-((R)-1-(tert-Butyldimethylsilyloxy)ethyl)-4-oxoazetidin-2-yl acetate) (3R,4R)-4-乙酰氧基-3-[(R)-叔丁基二甲硅氧基)乙基]-2-氮杂环丁酮 |
| 76855-69-1 |
F-087006 |
1EA |
|
4-AA ((2R,3R)-3-((R)-1-(tert-Butyldimethylsilyloxy)ethyl)-4-oxoazetidin-2-yl acetate) (3R,4R)-4-乙酰氧基-3-[(R)-叔丁基二甲硅氧基)乙基]-2-氮杂环丁酮 |
| 76855-69-1 |
F-087006 |
1EA |
|
4-AA ((2R,3R)-3-((R)-1-(tert-Butyldimethylsilyloxy)ethyl)-4-oxoazetidin-2-yl acetate) (3R,4R)-4-乙酰氧基-3-[(R)-叔丁基二甲硅氧基)乙基]-2-氮杂环丁酮 |
| 76855-69-1 |
F-087006 |
1EA |
|
4-AA ((2R,3R)-3-((R)-1-(tert-Butyldimethylsilyloxy)ethyl)-4-oxoazetidin-2-yl acetate) (3R,4R)-4-乙酰氧基-3-[(R)-叔丁基二甲硅氧基)乙基]-2-氮杂环丁酮 |
| 7689-03-4 |
C-7317 |
1EA |
|
Camptothecin (Irinotecan EP Impurity D) |
| 7689-03-4 |
I-1811 |
1EA |
|
Irinotecan EP Impurity D (Camptothecin) |
| 77-36-1 |
C-102001 |
1EA |
|
Clortalidone 2-氯-5-(1-羟基-3-羰基异吲哚林-1-基)苯磺酰胺 |
| 77-36-1 |
C-140011 |
1EA |
|
Chlortalidone (Chlorthalidone) 2-氯-5-(1-羟基-3-羰基异吲哚林-1-基)苯磺酰胺 |
| 78162-58-0 |
M-6813 |
1EA |
|
Medetomidine Impurity 4 N,N-二甲基-1H-咪唑-1-磺酰胺 |
| 79660-72-3 |
F-120001 |
1EA |
|
Fleroxacin 氟罗沙星 |
| 79952-42-4 |
S-1218 |
1EA |
|
Simvastatin EP Impurity H 辛伐他汀内酯二醇 |
| 8047-67-4 |
S-070001 |
1EA |
|
Iron Sucrose 蔗糖铁 |
| 80756-85-0 |
C-935 |
1EA |
|
Ceftriaxone EP Impurity D (Z)-S-2-苯并噻唑基-2-氨基-alpha-(甲氧亚氨基)-4-噻唑硫代乙酸酯 |
| 81-81-2 |
W-015 |
1EA |
|
Warfarin 甲醇中杀鼠灵溶液，1μg/mL |
| 81-82-3 |
C-001001 |
1EA |
|
rac-Coumachlor 氯灭鼠灵 |
| 820-10-0 |
M-4710 |
1EA |
|
Methionine Sulfone DL-蛋氨酸砜 |
| 82419-35-0 |
L-2342 |
1EA |
|
Levofloxacin Impurity 27 9,1-二氟-2,3-二氢-3-甲基-7-氧-7H-吡啶并[1,2,3-de]-1,4-苯并恶嗪-6-甲酸 |
| 82419-35-0 |
L-2342 |
1EA |
|
Levofloxacin Impurity 27 9,1-二氟-2,3-二氢-3-甲基-7-氧-7H-吡啶并[1,2,3-de]-1,4-苯并恶嗪-6-甲酸 |
| 82640-04-8 |
R-0111 |
1EA |
|
Raloxifene HCl (6-羟基-2-(4-羟基苯基)苯并[b]噻吩-3-基)-(4-(2-(哌啶-1-基)乙氧基)苯基)甲酮 盐酸盐 |
| 82911-69-1 |
S-131003 |
1EA |
|
Fmoc-Osu (N-Fmoc-succinimide) N-(9-芴基甲氧基羰基)琥珀酰胺 |
| 837-52-5 |
P-228 |
1EA |
|
Piperaquine Impurity I [7-Chloro-4-(Piperazinyl)quinoline] 7-氯-4-哌嗪-1-基-喹啉 |
| 83928-76-1 |
G-271 |
1EA |
|
Gepirone 吉哌隆 |
| 83928-76-1 |
G-272 |
1EA |
|
Gepirone-d8 |
| 84110-34-9 |
B-4663 |
1EA |
|
Bortezomib Impurity 50 2-甲基丙烷硼酸(1S,2S,3R,5S)-(+)-2,3-蒎烷二醇 酯 |
| 847818-55-7 |
B-164001 |
1EA |
|
1-Methyl-1H-Pyrazole-4-Boronic Acid 1-甲基吡唑-4-硼酸 |
| 849206-43-5 |
O-0816 |
1EA |
|
Olmesartan Medoxomil EP Impurity B 奥美沙坦酯组分A |
| 849206-43-5 |
O-0816 |
1EA |
|
Olmesartan Medoxomil EP Impurity B 奥美沙坦酯组分A |
| 849217-64-7 |
F-186001 |
1EA |
|
Foretinib N-(3-氟-4-((6-甲氧基-7-(3-吗啉代丙氧基)喹啉-4-基)-氧基)苯基)-N-(4-氟苯基)环丙烷-1,1-二甲酰胺 |
| 851957-35-2 |
T-0510 |
1EA |
|
Topiramate Impurity 2 |
| 85440-79-5 |
I-139 |
1EA |
|
Indapamide EP Impurity A |
| 86357-09-7 |
G-168 |
1EA |
|
Ganciclovir EP Impurity E (iso-Ganciclovir) |
| 86728-85-0 |
E-6339 |
1EA |
|
Empagliflozin Impurity 24 (S)-(-)-4-氯-3-羟基丁酸乙酯, 97% |
| 874340-08-6 |
L-0737 |
1EA |
|
Linezolid Impurity 18 N-(3-酞酰亚胺基-2-(R)-羟基丙基)-3-氟-4-(吗啉基)苯胺 |
| 874340-08-6 |
L-0737 |
1EA |
|
Linezolid Impurity 18 N-(3-酞酰亚胺基-2-(R)-羟基丙基)-3-氟-4-(吗啉基)苯胺 |
| 874638-80-9 |
S-055034 |
1EA |
|
Sofosbuvir Impurity 30 ((2R,3R,4R)-3-(苄氧基)-4-氟-4-甲基-5-氧代四氢呋喃-2-基)甲基苯甲酸酯 |
| 87500-74-1 |
A-108001 |
1EA |
|
Aztreonam USP Related Compound A (Open-ring Aztreonam) Open Ring Aztreonam United States Pharmacopeia (USP) Reference Standard |
| 87500-74-1 |
A-108001 |
1EA |
|
Aztreonam USP Related Compound A (Open-ring Aztreonam) Open Ring Aztreonam United States Pharmacopeia (USP) Reference Standard |
| 877399-52-5 |
C-123001 |
1EA |
|
Crizotinib |
| 88-12-0 |
P-721 |
1EA |
|
Povidone EP Impurity A (1-Vinylpyrrolidin-2-one) N-乙烯基-2-吡咯烷酮 |
| 88046-01-9 |
F-1913 |
1EA |
|
Famotidine EP Impurity H DiHCl |
| 88046-01-9 |
F-1913 |
1EA |
|
Famotidine EP Impurity H DiHCl |
| 885477-83-8 |
R-09113 |
1EA |
|
Rosuvastatin Impurity 55 ((4-(4-氟苯基)-6-异丙基-2-(N-甲基甲基磺酰胺基)-嘧啶-5-基)甲基)三苯基溴化膦 |
| 88570-74-5 |
F-107014 |
1EA |
|
Flomoxef Impurity 12 |
| 898224-95-8 |
B-4321 |
1EA |
|
Bendamustine Related Impurity 5 |
| 898543-06-1 |
R-2925 |
1EA |
|
Rivaroxaban Impurity 11 HCl 利伐沙班中间体 |
| 898543-06-1 |
R-2925 |
1EA |
|
Rivaroxaban Impurity 11 HCl 利伐沙班中间体 |
| 898543-06-1 |
R-2925 |
1EA |
|
Rivaroxaban Impurity 11 HCl 利伐沙班中间体 |
| 9002-92-0 |
P-243001 |
1EA |
|
Polidocanol α-异十三烷基-ω-羟基-聚(氧-1,2-亚乙基) |
| 9002-92-0 |
P-243001 |
1EA |
|
Polidocanol α-异十三烷基-ω-羟基-聚(氧-1,2-亚乙基) |
| 9002-92-0 |
P-348001 |
1EA |
|
Polyoxyethylene Lauryl Ether (major component) 月桂醇聚氧乙烯醚 |
| 9002-92-0 |
P-348001 |
1EA |
|
Polyoxyethylene Lauryl Ether (major component) 月桂醇聚氧乙烯醚 |
| 90237-03-9 |
F-1911 |
1EA |
|
Famotidine Sulfoxide |
| 91147-43-2 |
B-164 |
1EA |
|
Brimonidine EP Impurity A (Brimonidine Impurity II) |
| 912456-61-2 |
T-0514 |
1EA |
|
Topiramate Impurity 5 托吡酯杂质5 |
| 92-55-7 |
N-472 |
1EA |
|
Nifuratel Impurity A (Nitrofurfural Diacetate) 5-硝基-2-糠醛二乙酸酯 |
| 92-55-7 |
N-472 |
1EA |
|
Nifuratel Impurity A (Nitrofurfural Diacetate) 5-硝基-2-糠醛二乙酸酯 |
| 92-84-2 |
P-185 |
1EA |
|
Promethazine EP Impurity A (Phenothiazine) 吩噻嗪，99% |
| 93-35-6 |
U-014001 |
1EA |
|
Umbelliferone 7-羟基香豆素 |
| 93246-53-8 |
L-0747 |
1EA |
|
Linezolid Impurity 28 3-氟-4-(4-吗啉基)苯胺 |
| 947723-87-7 |
C-1066 |
1EA |
|
Cefuroxime Axetil EP Impurity E |
| 947723-87-7 |
C-1066 |
1EA |
|
Cefuroxime Axetil EP Impurity E |
| 95-25-0 |
C-223 |
1EA |
|
Chlorzoxazone-d3 |
| 95-25-0 |
C-225 |
1EA |
|
Chlorzoxazone 5-氯-2(3H)-苯并噁唑酮 |
| 95153-31-4 |
P-061 |
1EA |
|
Perindoprilat 培哚普利 |
| 95153-31-4 |
P-061 |
1EA |
|
Perindoprilat 培哚普利 |
| 957054-30-7 |
P-268001 |
1EA |
|
Pictilisib (GDC-0941) 2-(1H-吲唑-4-基)-6-(4-甲烷磺酰基哌嗪-1-基甲基)-4-吗啉-4-基-噻吩并[3,2-d]嘧啶 |
| 957054-30-7 |
P-268001 |
1EA |
|
Pictilisib (GDC-0941) 2-(1H-吲唑-4-基)-6-(4-甲烷磺酰基哌嗪-1-基甲基)-4-吗啉-4-基-噻吩并[3,2-d]嘧啶 |
| 957054-30-7 |
P-268001 |
1EA |
|
Pictilisib (GDC-0941) 2-(1H-吲唑-4-基)-6-(4-甲烷磺酰基哌嗪-1-基甲基)-4-吗啉-4-基-噻吩并[3,2-d]嘧啶 |
| 95713-52-3 |
A-155007 |
1EA |
|
(2,4-Dinitro-5-fluorophenyl) L-Alaninamide Nα-(5-氟-2,4-二硝基苯基)-L-丙氨酰胺[用于e.e.值测定的HPLC标记试剂] |
| 95713-52-3 |
A-155007 |
1EA |
|
(2,4-Dinitro-5-fluorophenyl) L-Alaninamide Nα-(5-氟-2,4-二硝基苯基)-L-丙氨酰胺[用于e.e.值测定的HPLC标记试剂] |
| 96-53-7 |
T-9917 |
1EA |
|
Tebipenem Pivoxil Impurity 9 2-巯基噻唑啉 |
| 97240-80-7 |
T-053 |
1EA |
|
Topiramate N-Methyl Impurity 托吡酯N-甲基杂质 |
| 97614-43-2 |
C-115015 |
1EA |
|
Clofarabine Impurity 6 2-脱氧-2-氟-1,3,5-三苯甲酰基-alpha-D-阿拉伯呋喃糖 |
| 97963-62-7 |
P-0113 |
1EA |
|
Pantoprazole EP Impurity C 5-(二氟甲氧基)-2-巯基苯并咪唑 |
| 97963-62-7 |
P-0113 |
1EA |
|
Pantoprazole EP Impurity C 5-(二氟甲氧基)-2-巯基苯并咪唑 |
| 98-79-3 |
PG-355 |
1EA |
|
L-Pyroglutamic Acid (S)-(-)-2-吡咯烷酮-5-甲酸 |
| 98-79-3 |
PG-355 |
1EA |
|
L-Pyroglutamic Acid (S)-(-)-2-吡咯烷酮-5-甲酸 |
| 98760-08-8 |
A-7722 |
1EA |
|
Atazanavir Impurity 17 (2R,3S)-1,2-环氧基-3-(Boc-氨基)-4-苯基丁烷 |
| 989-38-8 |
R-124001 |
1EA |
|
Rhodamine 6G 罗丹明6G |
粤ICP备20060492号-2
